Anti-Human CD16 SAFIRE Purified


The CB15 monoclonal antibody specifically binds to human CD16, a low affinity Fc receptor. It is expressed on NK, neutrophils, macrophages, monocytes, and placental trophoblasts. CD16 is expressed in CD16a and CD16b forms. CD16a is a polyeptide anchored transmembrane protein and CD16b is a monomeric glycosylphosphatidylinositol (GPI)-anchored protein found in neutrophils. CD16 is reported to be involved in NK cell activation and signal transduction. BMN-673

Clone
CB16
Format:
SAFIRE Purified
Applications
FC, FA
Reactivity
Human
Isotype:
Mouse IgG1
Research Interest:
Cell Type: ,
Preperation:
The product should be stored undiluted at 4°C. Do not freeze. The monoclonal antibody was purified utilizing affinity chromatography. The endotoxin level is determined by LAL test to be less than 0.01 EU/µg of the protein.
Formulation:
Phosphate-buffered aqueous solution, ph7.2.
References:

Wirthmueller, U., Kurosaki, T., Murakami, M. S., & Ravetch, J. V. (1992). Signal transduction by Fc gamma RIII (CD16) is mediated through the gamma chain. The Journal of experimental medicine175(5), 1381-1390.

Deaglio, S., Zubiaur, M., Gregorini, A., Bottarel, F., Ausiello, C. M., Dianzani, U., … & Malavasi, F. (2002). Human CD38 and CD16 are functionally dependent and physically associated in natural killer cells. Blood99(7), 2490-2498.

Araya, N., Takahashi, K., Sato, T., Nakamura, T., Sawa, C., Hasegawa, D., … & Yamano, Y. (2011). Fucoidan therapy decreases the proviral load in patients with human T-lymphotropic virus type-1-associated neurological disease.Antiviral therapy16(1), 89.

MED: 19038620

Anti-Human CD16 SAFIRE Purified


The 3G8 monoclonal antibody specifically reacts with human CD16, the low affinity IgG receptor III (FC gamma RIII). CD16 is expressed on granulocytes, monocytes, macrophages, and NK cells and plays a role in NK activation and signal transduction. CD16 is expressed as either CD16a or CD16b. CD16a is a polypeptide-anchored transmembrane protein and CD16b is a glycosylphosphatidylinositol (GPI)-anchored protein that is expressed exclusively on neutrophils. IPI549

Clone
3G8
Format:
SAFIRE Purified
Applications
FC, FA
Reactivity
Human
Isotype:
Mouse IgG1, kappa
Research Interest:
Cell Type: ,
Preperation:
The product should be stored undiluted at 4°C and should be protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified utilizing affinity chromatography.
Formulation:
Phosphate-buffered aqueous solution, ph7.2
References:
Choi, E. I., Wang, R., Peterson, L., Letvin, N. L., Reimann, K. A. (2008). Use of an anti‐CD16 antibody for in vivo depletion of natural killer cells in rhesus macaques. Immunology124(2), 215-222.

Perussia, B. I. C. E., & Trinchieri, G. I. O. R. G. I. O. (1984). Antibody 3G8, specific for the human neutrophil Fc receptor, reacts with natural killer cells. The Journal of Immunology132(3), 1410-1415.

Vossebeld, P. J., Homburg, C. H., Roos, D., & Verhoeven, A. J. (1997). The anti-FcγRIII mAb 3G8 induces neutrophil activation via a cooperative action of FcγRIIIb and FcγRIIa. The international journal of biochemistry & cell biology,29(3), 465-473.

MED: 19038625

Anti-Human CD16 SAFIRE Purified


The 3G8 monoclonal antibody specifically reacts with human CD16, the low affinity IgG receptor III (FC gamma RIII). CD16 is expressed on granulocytes, monocytes, macrophages, and NK cells and plays a role in NK activation and signal transduction. CD16 is expressed as either CD16a or CD16b. CD16a is a polypeptide-anchored transmembrane protein and CD16b is a glycosylphosphatidylinositol (GPI)-anchored protein that is expressed exclusively on neutrophils. Fulvestrant

Clone
3G8
Format:
SAFIRE Purified
Applications
FC, FA
Reactivity
Human
Isotype:
Mouse IgG1, kappa
Research Interest:
Cell Type: ,
Preperation:
The product should be stored undiluted at 4°C and should be protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified utilizing affinity chromatography.
Formulation:
Phosphate-buffered aqueous solution, ph7.2
References:
Choi, E. I., Wang, R., Peterson, L., Letvin, N. L., Reimann, K. A. (2008). Use of an anti‐CD16 antibody for in vivo depletion of natural killer cells in rhesus macaques. Immunology124(2), 215-222.

Perussia, B. I. C. E., & Trinchieri, G. I. O. R. G. I. O. (1984). Antibody 3G8, specific for the human neutrophil Fc receptor, reacts with natural killer cells. The Journal of Immunology132(3), 1410-1415.

Vossebeld, P. J., Homburg, C. H., Roos, D., & Verhoeven, A. J. (1997). The anti-FcγRIII mAb 3G8 induces neutrophil activation via a cooperative action of FcγRIIIb and FcγRIIa. The international journal of biochemistry & cell biology,29(3), 465-473.

MED: 19047229

Anti-Human CD16 SAFIRE Purified


The CB15 monoclonal antibody specifically binds to human CD16, a low affinity Fc receptor. It is expressed on NK, neutrophils, macrophages, monocytes, and placental trophoblasts. CD16 is expressed in CD16a and CD16b forms. CD16a is a polyeptide anchored transmembrane protein and CD16b is a monomeric glycosylphosphatidylinositol (GPI)-anchored protein found in neutrophils. CD16 is reported to be involved in NK cell activation and signal transduction. BQ-789 (sodium salt)

Clone
CB16
Format:
SAFIRE Purified
Applications
FC, FA
Reactivity
Human
Isotype:
Mouse IgG1
Research Interest:
Cell Type: ,
Preperation:
The product should be stored undiluted at 4°C. Do not freeze. The monoclonal antibody was purified utilizing affinity chromatography. The endotoxin level is determined by LAL test to be less than 0.01 EU/µg of the protein.
Formulation:
Phosphate-buffered aqueous solution, ph7.2.
References:

Wirthmueller, U., Kurosaki, T., Murakami, M. S., & Ravetch, J. V. (1992). Signal transduction by Fc gamma RIII (CD16) is mediated through the gamma chain. The Journal of experimental medicine175(5), 1381-1390.

Deaglio, S., Zubiaur, M., Gregorini, A., Bottarel, F., Ausiello, C. M., Dianzani, U., … & Malavasi, F. (2002). Human CD38 and CD16 are functionally dependent and physically associated in natural killer cells. Blood99(7), 2490-2498.

Araya, N., Takahashi, K., Sato, T., Nakamura, T., Sawa, C., Hasegawa, D., … & Yamano, Y. (2011). Fucoidan therapy decreases the proviral load in patients with human T-lymphotropic virus type-1-associated neurological disease.Antiviral therapy16(1), 89.

MED: 19047230

Related Post